Pharmaceuticals

Global Anticoagulants Market Size, Forecasts, And Opportunities

October 29, 2021 by The Business Research Company

Learn about the global anticoagulants market through The Business Research Company, which provides information on anticoagulants market size, anticoagulants market drivers and restraints, anticoagulants market players, the COVID-19 impact on the anticoagulants market, and more.

The global anticoagulants market is expected to grow from $32.09 billion in 2020 to $36.50 billion in 2021 at a compound annual growth rate (CAGR) of 13.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anticoagulants market is expected to reach $51.32 billion in 2025 at a CAGR of 8.9%.

The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years.

Request A Sample For The Global Anticoagulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots. Anticoagulants are referred to as blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.

Global anticoagulants market segments include:

By Drug Class: Factor XA Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Others

By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Others

By End User: Hospitals, Homecare, Specialty Centers, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the anticoagulants market in 2020.

The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19 related blood clotting in adults.

TBRC’s anticoagulants market report covers:

Major Market Players: GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka, Leo Pharma, Eisai Co. Ltd, and Amphastar Pharmaceutica.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Anticoagulants Global Market Report 2021: COVID-19 Impact and Recovery to 2030 is one of a series of new reports from The Business Research Company that provides anticoagulants market overviews, analyzes and forecasts market size, share, anticoagulants market players, anticoagulants market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s anticoagulants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Blood And Blood Components Global Market Report 2021: COVID-19 Growth And Change To 2030

Cardiovascular Devices Global Market Report 2021: COVID-19 Impact And Recovery

Pharmaceutical Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model